Source: StreetInsider

Press Release: Genentech : FDA sends warning to company for marketing dangerous unapproved stem cell products that put patients at risk and puts other stem cell firms, providers on notice

SILVER SPRING, Md., Dec. 20, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration has warned Genetech, Inc. of San Diego, California and its president, Edwin N. Pinos for marketing stem cell products without FDA approval and for significant deviations from current good tissue practice (CGTP) and current good manufacturing practice (CGMP) requirements, including some violations that may have led to microbial contamination, potentially causing serious blood infections in patients.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Estimated Annual Revenue

Estimated Employees

Alexander Hardy's photo - CEO of Genentech


Alexander Hardy

CEO Approval Rating


Genentech is a biotechnology company that discovers, develops and commercializes medicines to treat patients with life-t... Read more